AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUM SOLUTION

Land: Canada

Språk: engelsk

Kilde: Health Canada

Aktiv ingrediens:

GLUTAMIC ACID; GLYCINE; HISTIDINE; L-PROLINE; SERINE; ACETYL-L-TYROSINE; DEXTROSE; SODIUM CHLORIDE; L-ISOLEUCINE; L-LEUCINE; L-LYSINE (L-LYSINE ACETATE); METHIONINE; L-PHENYLALANINE; L-THREONINE; TRYPTOPHAN; L-VALINE; L-ALANINE; L-ARGININE; L-ASPARTIC ACID; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; CALCIUM CHLORIDE; POTASSIUM PHOSPHATE DIBASIC

Tilgjengelig fra:

HOSPIRA HEALTHCARE ULC

ATC-kode:

B05BA10

INN (International Name):

COMBINATIONS

Dosering :

258MG; 175MG; 105MG; 252MG; 185MG; 94MG; 25G; 205MG; 231MG; 350MG; 368MG; 60MG; 104MG; 140MG; 70MG; 175MG; 348MG; 356MG; 245MG; 22MG; 51MG; 37MG; 261MG

Legemiddelform:

SOLUTION

Sammensetning:

GLUTAMIC ACID 258MG; GLYCINE 175MG; HISTIDINE 105MG; L-PROLINE 252MG; SERINE 185MG; ACETYL-L-TYROSINE 94MG; DEXTROSE 25G; SODIUM CHLORIDE 205MG; L-ISOLEUCINE 231MG; L-LEUCINE 350MG; L-LYSINE (L-LYSINE ACETATE) 368MG; METHIONINE 60MG; L-PHENYLALANINE 104MG; L-THREONINE 140MG; TRYPTOPHAN 70MG; L-VALINE 175MG; L-ALANINE 348MG; L-ARGININE 356MG; L-ASPARTIC ACID 245MG; POTASSIUM CHLORIDE 22MG; MAGNESIUM CHLORIDE 51MG; CALCIUM CHLORIDE 37MG; POTASSIUM PHOSPHATE DIBASIC 261MG

Administreringsrute:

INTRAVENOUS

Enheter i pakken:

1000ML

Resept typen:

Ethical

Terapeutisk område:

CALORIC AGENTS

Produkt oppsummering:

Active ingredient group (AIG) number: 2350890004; AHFS:

Autorisasjon status:

CANCELLED POST MARKET

Autorisasjon dato:

2012-08-03

Preparatomtale

PRESCRIBING INFORMATION
AMINOSYN® II IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
WITH CALCIUM
NUTRIMIX® DUAL CHAMBER CONTAINERS
Nutritive with and without Electrolyte Supplements for Intravenous
Infusion
Hospira Healthcare Corporation
DATE OF PREPARATION:
5400 Côte-de-Liesse
May 28, 2004
Town of Mount Royal (QC), CANADA
H4P 1A5
Control#: 091791, 091794, 091796, 091797, 091802, 091806
- 2 -
PRESCRIBING INFORMATION
NAME OF DRUGS
AMINOSYN® II IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
WITH CALCIUM
NUTRIMIX® DUAL CHAMBER CONTAINERS
THERAPEUTIC OR PHARMACOLOGICAL CLASSIFICATION
Nutritive with and without Electrolyte Supplements for Intravenous
Infusion
CLINICAL PHARMACOLOGY
Total parenteral nutrition consists of appropriate amino acids,
electrolytes, trace metals, vitamins
and an energy source. This may be accomplished by administering
AMINOSYN® II (amino acids)
with or without electrolytes, fat emulsion plus concentrated dextrose,
vitamins and trace metals.
AMINOSYN® II (an amino acid injection) with or without Electrolytes
in Dextrose Injection with or
without Calcium obtained after thoroughly mixing the contents of the
two chambers provides
carbohydrate calories and amino acids to promote protein synthesis and
wound healing, to reduce
the rate of endogenous protein catabolism and to minimize liver
glycogen depletion.
INDICATIONS AND CLINICAL USES
1. PERIPHERAL VEIN ADMINISTRATION
AMINOSYN® II 3.5% in 5% Dextrose Injection and AMINOSYN® II 3.5% M
(amino acid injection
3.5% with maintenance electrolytes) in 5% Dextrose Injection are
indicated for peripheral vein
infusion as a source of nitrogen in the intravenous treatment of acute
surgical patients with
adequate store of body fat, in whom, for short periods of time, oral
nutrition cannot be tolerated or
is not desirable. In such instances, the patients' energy needs are
met from their ow